Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 23Neoplasm Metastasis 9Squamous Cell Carcinoma of Head and Neck 3Triple Negative Breast Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Melanoma 2Lymphangioma 2Hyperglycemia 2Head and Neck Squamous Cell Cancer 2Vascular Malformations 1Uveal Melanoma 1Stomach Neoplasms 1Solid Tumor 1Skin Diseases, Vascular 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Hormone Receptor Positive Breast Carcinoma 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Exanthema 1

Interventions

Cisplatin 21pembrolizumab 16Gemcitabine 16Paclitaxel 15Radiotherapy 14Carboplatin 14Radiotherapy, Intensity-Modulated 13Cyclophosphamide 9Cetuximab 9Magnetic Resonance Spectroscopy 8Radiation 7padeliporfin 6Specimen Handling 6Oxaliplatin 6Fluorouracil 6Drug Therapy 6Docetaxel 6Capecitabine 6Bevacizumab 6anlotinib 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Celecoxib 5poly ICLC 4fludarabine 4Standard of Care 4Sorafenib 4Leucovorin 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma × Alpelisib × Clear all
NCT02298595 2017-11-13

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

University of Pittsburgh

Phase 1/2 Withdrawn
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡